Skip to main
ALC

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 30%
Sell 10%
Strong Sell 0%

Bulls say

Alcon is well positioned for long-term growth. Its strong presence in the vision care market, particularly in the US, and its continued investments in innovative products such as PanOptix and Vivity, show promising signs for maintaining its market share and driving future growth. The increase in adoption of advanced products such as Tryptyr and Systane in the Ocular Health segment also adds to the company's potential to drive strong top-line growth. Additionally, Alcon's decision to discontinue development of its PowerVision product and instead collaborate with RxSight for post-operative adjustable presbyopic correction IOLs shows the company's commitment to adapting to changing market trends and staying ahead of competition. Furthermore, Alcon's strong financial performance, with double-digit earnings growth and steady operating margins, showcases its ability to effectively manage costs and leverage its global presence. This, combined with its stable balance sheet and healthy cash flows, strengthens the company's ability to invest in research and development and pursue potential acquisitions to drive future growth. Overall, Alcon's strong market presence, innovative product pipeline, and solid financial performance make it a promising investment opportunity for long-term growth potential. However, risks such as slower market growth rates and increased competition in key areas should be monitored closely.

Bears say

Alcon is a leading visioncare and surgical company that operates in two segments and controls about one fourth of the US contact lens market. The company has potential for mid-single digit revenue growth and continued margin improvement due to strong product launches in high growth categories. However, risks such as weaker revenue growth and slower margin improvement could hinder the company's success.

ALC has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 30% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 10 analysts, ALC has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.